P300 in obsessive-compulsive disorder: Source localization and the effects of treatment

Journal of Psychiatric Research

Volumn 47, Issue 12, 2013, Pages 1975-1983

  Andreou, Christina ^a   Leicht, Gregor ^a   Popescu, Vlad ^b   Pogarell, Oliver ^b   Mavrogiorgou, Paraskevi ^c   Rujescu, Dan ^d   Giegling, Ina ^d   Zaudig, Michael ^e   Juckel, Georg ^c   Hegerl, Ulrich ^f   Mulert, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e Psychosomatic Hospital Windach   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

EEG; Frontal cortex; LORETA; Neuroimaging; Obsessive compulsive disorder; P300

Indexed keywords

SERTRALINE;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERANCE; DSM-IV; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; FRONTAL CORTEX; HUMAN; HYPERACTIVITY; INFERIOR TEMPORAL CORTEX; LEFT HEMISPHERE; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE FRONTAL GYRUS; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UNCERTAINTY; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EEG; FRONTAL CORTEX; LORETA; NEUROIMAGING; OBSESSIVE-COMPULSIVE DISORDER; P300;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CASE-CONTROL STUDIES; COGNITIVE THERAPY; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SERTRALINE; YOUNG ADULT;

EID: 84886085494     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.09.003     Document Type: Article

References (86)

1. Alptekin K., Degirmenci B., Kivircik B., Durak H., Yemez B., Derebek E., et al. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression. Psychiatry Res 2001, 107:51-56.
2. Aouizerate B., Guehl D., Cuny E., Rougier A., Bioulac B., Tignol J., et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004, 72:195-221.
3. Balconi M., Crivelli D. FRN and P300 ERP effect modulation in response to feedback sensitivity: the contribution of punishment-reward system (BIS/BAS) and behaviour identification of action. Neurosci Res 2010, 66:162-172.
4. Baxter L.R. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. JClin Psychiatry 1990, 51(Suppl):22-25. discussion 26.
5. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992, 49:681-689.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
7. Bergqvist P.B., Bouchard C., Blier P. Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder. Biol Psychiatry 1999, 45:164-174.
8. Brazdil M., Dobsik M., Mikl M., Hlustik P., Daniel P., Pazourkova M., et al. Combined event-related fMRI and intracerebral ERP study of an auditory oddball task. Neuroimage 2005, 26:285-293.
9. Breiter H.C., Rauch S.L. Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 1996, 4:S127-S138.
10. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996, 53:595-606.
11. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 2005, 29:399-419.
12. Clark C.R., McFarlane A.C., Weber D.L., Battersby M. Enlarged frontal P300 to stimulus change in panic disorder. Biol Psychiatry 1996, 39:845-856.
13. Collins D., Neelin P., Peters T., Evans A. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. JComp Assist Tomogr 1994, 151:159-167.
14. Crino R.D., Andrews G. Obsessive-compulsive disorder and axis I comorbidity. Anx Disord 1996, 10:37-46.
15. Deister A. Zwangsstörungen. Psychiatrie 1995, 116-126. Hippokrates Verlag, Stuttgart. H.J. Möller, G. Laux, A. Deister (Eds.).
16. Duncan C.C., Barry R.J., Connolly J.F., Fischer C., Michie P.T., Naatanen R., et al. Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 2009, 120:1883-1908.
17. Elliott R., Deakin B. Role of the orbitofrontal cortex in reinforcement processing and inhibitory control: evidence from functional magnetic resonance imaging studies in healthy human subjects. Int Rev Neurobiol 2005, 65:89-116.
18. Evans D.W., Lewis M.D., Iobst E. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain Cogn 2004, 55:220-234.
19. Evans D.W., Maliken A. Cortical activity and children's rituals, habits and other repetitive behavior: a visual P300 study. Behav Brain Res 2011, 224:174-179.
20. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured clinical Interview for DSM-IV axis II personality disorders, (SCID-II) 1997, American Psychiatric Press, Inc, Washington, D.C.
21. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 1983, 63:844-914.
22. Gohle D., Juckel G., Mavrogiorgou P., Pogarell O., Mulert C., Rujescu D., et al. Electrophysiological evidence for cortical abnormalities in obsessive-compulsive disorder - a replication study using auditory event-related P300 subcomponents. JPsychiatr Res 2008, 42:297-303.
23. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989, 46:1006-1011.
24. Graybiel A.M., Rauch S.L. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000, 28:343-347.
25. Greenberg B.D., Murphy D.L., Rasmussen S.A. Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. Psychiatr Clin North Am 2000, 23:671-686. xii.
26. Greenberg B.D., Price L.H., Rauch S.L., Friehs G., Noren G., Malone D., et al. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin N Am 2003, 14:199-212.
27. Greisberg S., McKay D. Neuropsychology of obsessive-compulsive disorder: a review and treatment implications. Clin Psychol Rev 2003, 23:95-117.
28. Gunduz-Bruce H., Reinhart R.M., Roach B.J., Gueorguieva R., Oliver S., D'Souza D.C., et al. Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry 2012, 71:969-977.
29. Guy W. ECDEU assessment manual for psychopharmacology 1976, Department of Health, Education and Welfare, Washington, D.C.
30. Hämäläinen M.S., Hari R., Ilmoniemi R.J., Knuutila J., Lounasmaa O.V. Magnetoencephalography-theory, instrumentation, and application to noninvasive studies of the working human brain. Rev Mod Phys 1993, 65:413-497.
31. Hamilton M. Arating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-62.
32. Hansen E.S., Hasselbalch S., Law I., Bolwig T.G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol 2002, 5:1-10.
33. Henry J.D. Ameta-analytic review of Wisconsin card sorting test and verbal fluency performance in obsessive-compulsive disorder. Cogn Neuropsychiatry 2006, 11:156-176.
34. Hodgson R.J., Rachman S. Obsessional-compulsive complaints. Behav Res Ther 1977, 15:389-395.
35. Holmes A.J., Pizzagalli D.A. Spatiotemporal dynamics of error processing dysfunctions in major depressive disorder. Arch Gen Psychiatry 2008, 65:179-188.
36. Huey E.D., Zahn R., Krueger F., Moll J., Kapogiannis D., Wassermann E.M., et al. Apsychological and neuroanatomical model of obsessive-compulsive disorder. JNeuropsychiatry Clin Neurosci 2008, 20:390-408.
37. Karniski W., Blair R.C. Topographical and temporal stability of the P300. Electroencephalogr Clin Neurophysiol 1989, 72:373-383.
38. Kuelz A.K., Hohagen F., Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biol Psychol 2004, 65:185-236.
39. Lacerda A.L., Dalgalarrondo P., Caetano D., Camargo E.E., Etchebehere E.C., Soares J.C. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res 2003, 123:125-134.
40. Laux L., Glanzmann P., Schaffner P., Spielberger C.D. Fragebogen zur Erfassung von State- und Trait-Angst (STAI-G) 1981, Beltz, Weinheim.
41. Lazarus A. Multimodale Verhaltenstherapie 1978, Fachbuchhandlung für Psychologie, Frankfurt am Main.
42. Linden D.E. The p300: where in the brain is it produced and what does it tell us?. Neuroscientist 2005, 11:563-576.
43. Malloy P., Rasmussen S., Braden W., Haier R.J. Topographic evoked potential mapping in obsessive-compulsive disorder: evidence of frontal lobe dysfunction. Psychiatry Res 1989, 28:63-71.
44. Mavrogiorgou P., Juckel G., Frodl T., Gallinat J., Hauke W., Zaudig M., et al. P300 subcomponents in obsessive-compulsive disorder. JPsychiatr Res 2002, 36:399-406.
45. McGuire P.K., Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S., Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994, 164:459-468.
46. Melcher T., Falkai P., Gruber O. Functional brain abnormalities in psychiatric disorders: neural mechanisms to detect and resolve cognitive conflict and interference. Brain Res Rev 2008, 59:96-124.
47. Melloni M., Urbistondo C., Sedeno L., Gelormini C., Kichic R., Ibanez A. The extended fronto-striatal model of obsessive compulsive disorder: convergence from event-related potentials, neuropsychology and neuroimaging. Front Hum Neurosci 2012, 6:259.
48. Menzies L., Chamberlain S.R., Laird A.R., Thelen S.M., Sahakian B.J., Bullmore E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008, 32:525-549.
49. Mergl R., Mavrogiorgou P., Juckel G., Zaudig M., Hegerl U. Can a subgroup of OCD patients with motor abnormalities and poor therapeutic response be identified?. Psychopharmacology (Berl) 2005, 179:826-837.
50. Morault P.M., Bourgeois M., Laville J., Bensch C., Paty J. Psychophysiological and clinical value of event-related potentials in obsessive-compulsive disorder. Biol Psychiatry 1997, 42:46-56.
51. Mulert C., Juckel G., Augustin H., Hegerl U. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002, 113:1566-1572.
52. Mulert C., Pogarell O., Juckel G., Rujescu D., Giegling I., Rupp D., et al. The neural basis of the P300 potential. Focus on the time-course of the underlying cortical generators. Eur Arch Psychiatry Clin Neurosci 2004, 254:190-198.
53. Nakao T., Nakagawa A., Yoshiura T., Nakatani E., Nabeyama M., Sanematsu H., et al. Duration effect of obsessive-compulsive disorder on cognitive function: a functional MRI study. Depress Anxiety 2009, 26:814-823.
54. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002, 15:1-25.
55. O'Neill J., Halgren E., Marinkovic K., Siembieda D., Refai D., Fitten L.J., et al. Effects of muscarinic and adrenergic agonism on auditory P300 in the macaque. Physiol Behav 2000, 70:163-170.
56. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
57. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 1994, 18:49-65.
58. Pinto A., Mancebo M.C., Eisen J.L., Pagano M.E., Rasmussen S.A. The Brown longitudinal obsessive compulsive study: clinical features and symptoms of the sample at intake. JClin Psychiatry 2006, 67:703-711.
59. Pizzagalli D., Lehmann D., Koenig T., Regard M., Pascual-Marqui R.D. Face-elicited ERPs and affective attitude: brain electric microstate and tomography analyses. Clin Neurophysiol 2000, 111:521-531.
60. Polich J. P300 clinical utility and control of variability. JClin Neurophysiol 1998, 15:14-33.
61. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007, 118:2128-2148.
62. Radua J., Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 2009, 195:393-402.
63. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994, 51:62-70.
64. Rice J.P., Reich T., Bucholz K.K., Neuman R.J., Fishman R., Rochberg N., et al. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 1995, 19:1018-1023.
65. Rubin R.T., Ananth J., Villanueva-Meyer J., Trajmar P.G., Mena I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 1995, 38:429-437.
66. Ruscio A.M., Stein D.J., Chiu W.T., Kessler R.C. The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication. Mol Psychiatry 2010, 15:53-63.
67. Sanz M., Molina V., Martin-Loeches M., Calcedo A., Rubia F.J. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients. Psychiatry Res 2001, 101:75-81.
68. Saxena S., Brody A.L., Ho M.L., Alborzian S., Ho M.K., Maidment K.M., et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 2001, 50:159-170.
69. Saxena S., Brody A.L., Ho M.L., Alborzian S., Maidment K.M., Zohrabi N., et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 2002, 59:250-261.
70. Saxena S., Brody A.L., Maidment K.M., Dunkin J.J., Colgan M., Alborzian S., et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999, 21:683-693.
71. Saxena S., Brody A.L., Maidment K.M., Smith E.C., Zohrabi N., Katz E., et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004, 161:1038-1048.
72. Saxena S., Brody A.L., Schwartz J.M., Baxter L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998, 26-37.
73. Saxena S., Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000, 23:563-586.
74. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996, 53:109-113.
75. Segalowitz S.J., Barnes K.L. The reliability of ERP components in the auditory oddball paradigm. Psychophysiology 1993, 30:451-459.
76. Stahl S.M. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. JAffect Disord 1998, 51:215-235.
77. Sturm V., Lenartz D., Koulousakis A., Treuer H., Herholz K., Klein J.C., et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. JChem Neuroanat 2003, 26:293-299.
78. Swick D., Pineda J.A., Schacher S., Foote S.L. Locus coeruleus neuronal activity in awake monkeys: relationship to auditory P300-like potentials and spontaneous EEG. Exp Brain Res 1994, 101:86-92.
79. Talairach J., Tournoux P. Co-planar stereotaxic atlas of the human brain 1988, Thieme, Stuttgart.
80. Taylor S. Assessment of obsessive-compulsive disorder. Obsessive-compulsive disorder: theory, research and treatment 1998, 229-257. Guilford Press, New York. R.P. Swinson, M.M. Antony, S. Rachman, M.A. Richter (Eds.).
81. Towey J., Bruder G., Hollander E., Friedman D., Erhan H., Liebowitz M., et al. Endogenous event-related potentials in obsessive-compulsive disorder. Biol Psychiatry 1990, 28:92-98.
82. Towey J., Bruder G., Tenke C., Leite P., DeCaria C., Friedman D., et al. Event-related potential and clinical correlates of neurodysfunction in obsessive-compulsive disorder. Psychiatry Res 1993, 49:167-181.
83. Towle V.L., Bolanos J., Suarez D., Tan K., Grzeszczuk R., Levin D.N., et al. The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy. Electroencephalogr Clin Neurophysiol 1993, 86:1-6.
84. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 2000, 57:1139-1147.
85. Volz K.G., Schubotz R.I., von Cramon D.Y. Why am I unsure? Internal and external attributions of uncertainty dissociated by fMRI. Neuroimage 2004, 21:848-857.
86. Winterer G., Mulert C., Mientus S., Gallinat J., Schlattmann P., Dorn H., et al. P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr 2001, 13:299-313.